TP53 and ovarian cancer: Type II (80–90%) includes undifferentiated carcinomas, carcinosarcomas, and the most common type of ovarian cancer, high-grade serous ovarian cancer (HGSOC), which is characterized by poor prognosis and high frequency of TP53 mutations.